Sign in →

Test ID ROC Rubeola (Measles) Antibodies, IgG and IgM (Separate Determinations), Spinal Fluid

Useful For

Diagnosis of central nervous system infection with rubeola (measles) virus and/or subacute sclerosing panencephalitis

Method Name

Immunofluorescence Assay (IFA)

Reporting Name

Rubeola (Measles) Ab, IgG,IgM, CSF

Specimen Type

CSF

Container/Tube: Sterile vial

Specimen Volume: 0.25 mL

Specimen Minimum Volume

0.1 mL

Specimen Stability Information

Specimen Type Temperature Time
CSF Refrigerated (preferred) 14 days
  Frozen  14 days

Clinical Information

Measles is a serious and highly contagious disease which can be a leading cause of death where nutrition and sanitation are limited. Onset begins with cough, fever, and lymphadenopathy approximately 2 weeks after exposure. Diagnosis is usually made when the rash appears. Koplik’s spots may be seen earlier on the buccal mucosa. Complications of measles may develop in children who appear to have normal immune functions.

 

Persistent infection of the central nervous system with measles virus is recognized to cause the disease subacute sclerosing panencephalitis (SSPE). SSPE is a rare, late complication of measles with an incidence of approximately 1 per 100,000 cases. SSPE is a progressive, usually fatal disease that occurs most often in children between the ages of 5 and 14. The onset is insidious and progressive. The incubation period from acute measles to onset of neurological symptoms varies from several months to many years. One of the most useful diagnostic tests involves the measurement of measles-specific antibodies in the cerebrospinal fluid (CSF) of patients with SSPE. Levels of antibody are significantly elevated in the CSF of SSPE patients compared to those without the disease.

Reference Values

IgG: <1:5

IgM: <1:10

Cautions

Detection of organism-specific antibodies in the cerebrospinal fluid (CSF) may suggest central nervous system infection. However, these results are unable to distinguish between intrathecal antibodies and serum antibodies introduced into the CSF at the time of lumbar puncture or from a breakdown in the blood-brain barrier. The results should be interpreted with other laboratory and clinical data prior to a diagnosis of central nervous system infection.

Day(s) Performed

Monday through Friday; 9 a.m.

Report Available

1 day

Performing Laboratory

Mayo Medical Laboratories in Rochester

Test Classification

This test has been modified from the manufacturer’s instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements.

CPT Code Information

86765 x 2

NY State Approved

No